01 January 2009 :
Clinical evaluation of busulfan, cladribine and alemtuzumab as reduced intensity conditioning for stem cell transplantation
Ann Transplant 2009; 14(2): 7-12 :: ID: 880525
HTML version available soon
01 January 2009 :
Ann Transplant 2009; 14(2): 7-12 :: ID: 880525
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.